Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1638 1651
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18005178 | APTAMER-BASED POINT-OF-CARE ASSAY DEVICES AND METHODS | Final Rejection | The Regents of the University of California |
| 18557772 | HYPERSIALYLATING CELLS | Non-Final OA | Novartis AG |
| 18103679 | METHODS FOR TREATING EXACERBATIONS OF INFLAMMATORY RESPIRATORY DISEASES | Non-Final OA | Hoffmann-La Roche Inc. |
| 18345803 | DEVICE AND METHODS FOR MEASURING PLATELET-FIBRIN CLOT CONTRACTION KINETICS | Non-Final OA | University of Kentucky Research Foundation |
| 18570470 | CHITINOLYTIC ENZYME-BASED PLANT PROTECTION AGENTS | Non-Final OA | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. |
| 18639238 | ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 18469214 | CANINE HEPATIC ORGANOIDS | Non-Final OA | Iowa State University Research Foundation, Inc. |
| 18579230 | AGENT FOR IMPROVING INTESTINAL FLORA | Non-Final OA | KEIO UNIVERSITY |
| 18550496 | METHOD FOR PRODUCING BRAIN ORGANOID INCLUDING AGGREGATED TAU PROTEIN | Non-Final OA | KEIO UNIVERSITY |
| 17918933 | METHODS AND COMPOSITIONS FOR IMPROVING SC-BETA CELLS OR ENHANCING THEIR UTILITY | Final Rejection | WASHINGTON UNIVERSITY |
| 18550546 | SYSTEM AND METHOD FOR ONLINE DETECTION OF A POST-TRANSLATIONAL MODIFICATION OF A POLYPEPTIDE | Non-Final OA | AstraZeneca AB |
| 18277676 | GUEST-HOST SUPRAMOLECULAR ASSEMBLY OF INJECTABLE HYDROGEL NANOFIBERS FOR CELL ENCAPSULATION | Non-Final OA | University of Virginia Patent Foundation |
| 18472931 | 3D MODELS FOR PREDICTING TREATMENT RESPONSES TO ALTERNATING ELECTRIC FIELDS | Non-Final OA | NOVOCURE GMBH |
| 18486770 | TREATMENT FOR METHAMPHETAMINE CARDIOVASCULAR DISEASE | Non-Final OA | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College |
| 17768846 | Hybrid Antimicrobial Protein Having Strong Bactericidal Effect and Application thereof | Non-Final OA | Jiangxi Yuansheng Biological Technology Co., Ltd. |
| 18286680 | METHOD FOR DETECTING EXOPOLYSACCHARIDE | Non-Final OA | MEIJI CO., LTD. |
| 18578768 | Enzymes and Uses Thereof | Non-Final OA | Samsara Eco Pty Limited |
| 18394679 | MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING MILK PRODUCTION | Non-Final OA | Native Microbials, Inc. |
| 18250808 | OSTEOGENIC COMPOSITION AND USE THEREOF | Non-Final OA | MEGAKARYON CORPORATION |
| 18570546 | New Microbial Diamine Oxidase Derived from Yarrowia Lipolytica for the Degradation of Biogenic Amines | Non-Final OA | UNIVERSITÄT HOHENHEIM |
| 18037339 | Cytochrome P450 Mutant Protein and Use Thereof | Non-Final OA | GsynBioT (Shanghai) Co., Ltd. |
| 18554448 | PHOSPHOKETOLASE VARIANTS AND METHODS OF USE | Non-Final OA | Genomatica, Inc. |
| 18551793 | 2-IMINOBIOTIN FOR USE IN THE TREATMENT OF STROKE | Non-Final OA | NEUROPHYXIA B.V. |
| 18276954 | Recombinant Human Acid Alpha-Glucosidase and Uses Thereof | Final Rejection | Amicus Therapeutics, Inc. |
| 18276356 | TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS) | Final Rejection | REGENXBIO RS LLC |
| 17798824 | METHOD AND DRUG FOR TREATING VIRAL PNEUMONIA | Non-Final OA | Talengen International Limited |
| 18004403 | METHODS AND COMPOSITIONS FOR PRODUCING VIRAL FUSOSOMES | Final Rejection | FLAGSHIP PIONEERING INNOVATIONS V, INC. |
| 18025513 | Methods for the Determination of Invasive Ability of Brain Tumour Cells and for the Diagnosis and Prognosis of Brain Tumour | Final Rejection | Institut Gustave Roussy |
| 17910812 | INTRACELLULAR SUBSTANCE INTRODUCTION AND EXTRACTION TECHNIQUE VIA COMPOSITE NANOTUBES | Final Rejection | Hynts Tech Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy